1-3 of 3
Andrea Newbold
Close
Sort by
Journal Articles

Combined inhibition of PI3K-related DNA damage response kinases and mTORC1 induces apoptosis in MYC-driven B-cell lymphomas

Jake Shortt, Benjamin P. Martin, Andrea Newbold, Katherine M. Hannan, Jennifer R. Devlin, Adele J. Baker, Rachael Ralli, Carleen Cullinane, Clemens A. Schmitt, Maurice Reimann, Michael N. Hall, Meaghan Wall, Ross D. Hannan, Richard B. Pearson, Grant A. McArthur, Ricky W. Johnstone
Journal: Blood
Blood (2013) 121 (15): 2964–2974.
https://doi.org/10.1182/blood-2012-08-446096
Published: 2013
Includes: Supplemental data
Journal Articles

The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacy

Leigh Ellis, Michael Bots, Ralph K. Lindemann, Jessica E. Bolden, Andrea Newbold, Leonie A. Cluse, Clare L. Scott, Andreas Strasser, Peter Atadja, Scott W. Lowe, Ricky W. Johnstone
Journal: Blood
Blood (2009) 114 (2): 380–393.
https://doi.org/10.1182/blood-2008-10-182758
Published: 2009
Includes: Supplemental data
Journal Articles

Defining the target specificity of ABT-737 and synergistic antitumor activities in combination with histone deacetylase inhibitors

Kate F. Whitecross, Amber E. Alsop, Leonie A. Cluse, Adrian Wiegmans, Kellie-Marie Banks, Claudia Coomans, Melissa J. Peart, Andrea Newbold, Ralph K. Lindemann, Ricky W. Johnstone
Journal: Blood
Blood (2009) 113 (9): 1982–1991.
https://doi.org/10.1182/blood-2008-05-156851
Published: 2009
Includes: Supplemental data